Quintrio
Home

BLANK CHECKS

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

OACC

Oaktree Acquisition Corp III Life Sciences is a blank check company.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $10.73 – $10.73
Volume 7
Market cap —

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for OACC.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for OACC.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update

Verona Pharma reported strong financial results for Q4 and 2024, with its product Ohtuvayre (ensifentrine) recording net sales of $36.6 million in Q4 and $42.3 million in 2024. The company also announced an amended strategic financing with Oaktree and OMERS, including a term loan facility increase and access to additional funding.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.